Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for KRYS

Stock Name	Krystal Biotech Inc
Ticker	KRYS(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US5011471027
LEI	549300YONUY68210OE41

Show aggregate KRYS holdings

News associated with KRYS

HC Wainwright Reaffirms Buy Rating for Krystal Biotech (NASDAQ:KRYS): Krystal Biotech (NASDAQ:KRYS – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $240.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 55.46% from the company’s current price. Several other research firms have also […] - 2025-09-17 02:56:43
Krystal Biotech, Inc. (NASDAQ:KRYS) Receives $210.38 Average PT from Analysts: Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average […] - 2025-09-11 02:46:50
Chardan Capital Lowers Krystal Biotech (NASDAQ:KRYS) Price Target to $216.00: Krystal Biotech (NASDAQ:KRYS – Free Report) had its price objective trimmed by Chardan Capital from $219.00 to $216.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a buy rating on the stock. Several other research analysts have also issued reports on KRYS. Citigroup reiterated a “neutral” rating and set […] - 2025-08-25 02:58:58
PNC Financial Services Group Inc. Grows Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS): PNC Financial Services Group Inc. grew its stake in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 27.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 2,141 shares of the company’s stock after acquiring an additional 461 shares during the period. PNC Financial Services Group Inc.’s […] - 2025-08-15 04:48:55
Krystal Biotech (NASDAQ:KRYS) Receives “Neutral” Rating from Citigroup: Krystal Biotech (NASDAQ:KRYS – Get Free Report)‘s stock had its “neutral” rating reiterated by equities researchers at Citigroup in a research note issued to investors on Tuesday, MarketBeat Ratings reports. They presently have a $166.00 price objective on the stock, down from their previous price objective of $176.00. Citigroup’s price target would indicate a potential […] - 2025-08-07 04:30:49
Federated Hermes Inc. Reduces Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS): Federated Hermes Inc. lowered its stake in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 2.0% during the 1st quarter, HoldingsChannel reports. The firm owned 12,781 shares of the company’s stock after selling 267 shares during the period. Federated Hermes Inc.’s holdings in Krystal Biotech were worth $2,304,000 as of its most recent filing with […] - 2025-08-06 06:28:56
Analysts Expect IJR Will Reach $131: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-05 07:38:03
Zurcher Kantonalbank Zurich Cantonalbank Has $1.04 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS): Zurcher Kantonalbank Zurich Cantonalbank lowered its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 5.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,742 shares of the company’s stock after selling 312 shares during the period. […] - 2025-08-05 05:06:52
Krystal Biotech (NASDAQ:KRYS) Sees Strong Trading Volume Following Strong Earnings: Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) saw strong trading volume on Monday after the company announced better than expected quarterly earnings. 279,432 shares traded hands during mid-day trading, a decline of 13% from the previous session’s volume of 319,447 shares.The stock last traded at $136.42 and had previously closed at $156.98. The company […] - 2025-08-05 02:20:51
Krystal Biotech Announces Approval Of VYJUVEK In Japan: (RTTNews) - Krystal Biotech (KRYS) announced that Japan's Ministry of Health, Labour and Welfare granted marketing authorization to VYJUVEK for the treatment of wounds in patients with dystrophic epidermolysis bullosa, starting from birth. VYJUVEK is the first genetic medicine ap - 2025-07-25 10:21:36
Teacher Retirement System of Texas Sells 578 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS): Teacher Retirement System of Texas cut its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 9.1% during the 1st quarter, HoldingsChannel.com reports. The fund owned 5,805 shares of the company’s stock after selling 578 shares during the period. Teacher Retirement System of Texas’ holdings in Krystal Biotech were worth $1,047,000 at […] - 2025-07-14 04:46:50
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Allspring Global Investments Holdings LLC: Allspring Global Investments Holdings LLC trimmed its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 82.6% during the first quarter, Holdings Channel reports. The institutional investor owned 5,180 shares of the company’s stock after selling 24,597 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Krystal Biotech were worth […] - 2025-07-09 04:42:14
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by New York State Teachers Retirement System: New York State Teachers Retirement System increased its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 0.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,979 shares of the company’s stock after purchasing an additional 100 shares during the […] - 2025-07-08 05:21:00
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 9.8% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 12,762 shares of the company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement […] - 2025-06-30 05:14:49
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lifted by GAMMA Investing LLC: GAMMA Investing LLC boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 50,249.4% during the first quarter, HoldingsChannel.com reports. The firm owned 121,342 shares of the company’s stock after acquiring an additional 121,101 shares during the period. GAMMA Investing LLC’s holdings in Krystal Biotech were worth $21,878,000 as of its […] - 2025-06-06 06:16:55
Janus Henderson Group PLC Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS): Janus Henderson Group PLC raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 16.1% during the fourth quarter, HoldingsChannel reports. The firm owned 10,071 shares of the company’s stock after purchasing an additional 1,400 shares during the quarter. Janus Henderson Group PLC’s holdings in Krystal Biotech were worth $1,579,000 as […] - 2025-05-23 05:19:08
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.39 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,205 shares of the company’s stock after selling 181 shares during the period. […] - 2025-05-22 06:30:46
Deutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS): Deutsche Bank AG boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 62.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,361 shares of the company’s stock after acquiring an additional 9,750 shares during the quarter. Deutsche […] - 2025-05-20 05:14:53
Citigroup Has Lowered Expectations for Krystal Biotech (NASDAQ:KRYS) Stock Price: Krystal Biotech (NASDAQ:KRYS – Free Report) had its target price decreased by Citigroup from $215.00 to $155.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock. A number of other brokerages have also recently issued reports on KRYS. HC Wainwright reissued a “buy” rating and issued […] - 2025-05-19 02:46:51
Krystal Biotech (NASDAQ:KRYS) Hits New 52-Week Low on Disappointing Earnings: Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) hit a new 52-week low during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $137.00 and last traded at $139.47, with a volume of 283299 shares traded. The stock had previously closed at $162.29. The company reported […] - 2025-05-08 02:24:46
Tuesday's ETF Movers: TAN, XBI: In trading on Tuesday, the Invesco Solar ETF is outperforming other ETFs, up about 3.2% on the day. Components of that ETF showing particular strength include shares of Shoals Technologies Group, up about 19.8% and shares of Solaredge Technologies, up about 16.3% on the day. A - 2025-05-06 13:09:13
Commit To Purchase Krystal Biotech At $150, Earn 16.3% Annualized Using Options: Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS) stock, but cautious about paying the going market price of $169.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in parti - 2025-04-30 12:44:33
102,061 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Purchased by Raymond James Financial Inc.: Raymond James Financial Inc. purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 102,061 shares of the company’s stock, valued at approximately $15,989,000. Raymond James Financial Inc. owned approximately 0.35% […] - 2025-04-22 05:45:14
Bank of Montreal Can Increases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS): Bank of Montreal Can grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 5.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,325 shares of the company’s stock after buying an additional 179 shares during the period. Bank of Montreal Can’s holdings in Krystal Biotech were worth $521,000 […] - 2025-04-22 04:50:52
Krystal Biotech, Inc. (NASDAQ:KRYS) Position Reduced by Invesco Ltd.: Invesco Ltd. reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 24.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 275,195 shares of the company’s stock after selling 90,356 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-17 05:57:00
Federated Hermes Inc. Has $2.04 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS): Federated Hermes Inc. raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,048 shares of the company’s stock after purchasing an additional 229 shares during the […] - 2025-04-14 06:20:51
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by JPMorgan Chase & Co.: JPMorgan Chase & Co. boosted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 151,835 shares of the company’s stock after buying an additional 23,934 shares during the period. JPMorgan Chase & Co.’s holdings in Krystal Biotech were worth $23,786,000 as of […] - 2025-04-10 05:07:14
Mitsubishi UFJ Asset Management Co. Ltd. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS): Mitsubishi UFJ Asset Management Co. Ltd. decreased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 13.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,367 shares of the company’s stock after selling 210 shares during the period. Mitsubishi UFJ […] - 2025-04-04 05:12:57
Sei Investments Co. Sells 13,085 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS): Sei Investments Co. cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 38.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,164 shares of the company’s stock after selling 13,085 shares during the quarter. Sei Investments Co.’s holdings in Krystal […] - 2025-04-04 04:38:46
4,300 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by KLP Kapitalforvaltning AS: KLP Kapitalforvaltning AS acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,300 shares of the company’s stock, valued at approximately $674,000. Other institutional investors also […] - 2025-04-02 05:12:54

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) KRYS holdings

Date	Number of KRYS Shares Held	Base Market Value of KRYS Shares	Local Market Value of KRYS Shares	Change in KRYS Shares Held	Change in KRYS Base Value	Current Price per KRYS Share Held	Previous Price per KRYS Share Held
2025-11-11 (Tuesday)	18,757	USD 3,807,671	USD 3,807,671	0	USD 65,087	USD 203	USD 199.53
2025-11-10 (Monday)	18,757	USD 3,742,584	USD 3,742,584	48	USD 39,512	USD 199.53	USD 197.93
2025-11-07 (Friday)	18,709	USD 3,703,072	USD 3,703,072	0	USD -38,167	USD 197.93	USD 199.97
2025-11-06 (Thursday)	18,709	USD 3,741,239	USD 3,741,239	48	USD 11,278	USD 199.97	USD 199.88
2025-11-05 (Wednesday)	18,661	USD 3,729,961	USD 3,729,961	0	USD -63,074	USD 199.88	USD 203.26
2025-11-04 (Tuesday)	18,661	USD 3,793,035	USD 3,793,035	48	USD 110,453	USD 203.26	USD 197.85
2025-11-03 (Monday)	18,613	USD 3,682,582	USD 3,682,582	0	USD 6,328	USD 197.85	USD 197.51
2025-10-31 (Friday)	18,613	USD 3,676,254	USD 3,676,254	0	USD 156,908	USD 197.51	USD 189.08
2025-10-30 (Thursday)	18,613	USD 3,519,346	USD 3,519,346	240	USD 119,422	USD 189.08	USD 185.05
2025-10-29 (Wednesday)	18,373	USD 3,399,924	USD 3,399,924	96	USD -66,309	USD 185.05	USD 189.65
2025-10-28 (Tuesday)	18,277	USD 3,466,233	USD 3,466,233	0	USD -5,118	USD 189.65	USD 189.93
2025-10-27 (Monday)	18,277	USD 3,471,351	USD 3,471,351	0	USD 69,453	USD 189.93	USD 186.13

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of KRYS by Blackrock for IE00BDZVHG35

Show aggregate share trades of KRYS

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 48 201.320 197.130 197.549 USD 9,482 165.45
2025-11-06 BUY 48 202.940 195.759 196.477 USD 9,431 165.08
2025-11-04 BUY 48 212.980 195.465 197.216 USD 9,466 164.68
2025-10-30 BUY 240 191.435 184.700 185.373 USD 44,490 164.18
2025-10-29 BUY 96 185.050 189.960 189.469 USD 18,189 164.06
2025-10-22 SELL -192 186.420 190.670 190.245 USD -36,527 163.37 Loss of -5,159 on sale
2025-10-20 BUY 96 195.960 196.775 196.693 USD 18,883 163.02
2025-10-17 BUY 240 190.230 192.910 192.642 USD 46,234 162.86
2025-10-15 BUY 384 192.990 195.385 195.145 USD 74,936 162.69
2025-10-03 BUY 336 183.360 183.580 183.558 USD 61,675 162.41
2025-10-02 BUY 48 181.690 182.280 182.221 USD 8,747 162.29
2025-09-30 BUY 96 176.530 178.200 178.033 USD 17,091 162.10
2025-09-26 BUY 96 167.820 168.190 168.153 USD 16,143 161.98
2025-09-25 BUY 96 161.150 164.385 164.061 USD 15,750 161.98
2025-09-18 BUY 50 160.610 160.690 160.682 USD 8,034 161.99
2025-09-17 BUY 150 154.050 157.100 156.795 USD 23,519 162.04
2025-07-17 SELL -100 150.150 153.740 153.381 USD -15,338 162.35 Profit of 897 on sale
2025-07-16 BUY 192 150.080 151.790 151.619 USD 29,111 162.43
2025-07-11 SELL -392 148.170 148.770 148.710 USD -58,294 162.70 Profit of 5,484 on sale
2025-07-02 BUY 2,695 141.350 143.045 142.875 USD 385,049 163.16
2025-06-25 BUY 98 142.500 146.775 146.347 USD 14,342 163.80
2025-06-20 BUY 464 132.460 133.700 133.576 USD 61,979 164.35
2025-06-11 BUY 96 139.620 143.200 142.842 USD 13,713 165.90
2025-06-10 BUY 96 138.210 138.523 138.492 USD 13,295 166.11
2025-06-04 SELL -48 132.030 134.030 133.830 USD -6,424 167.10 Profit of 1,597 on sale
2025-04-23 BUY 48 165.800 176.730 175.637 USD 8,431 174.96
2025-04-10 SELL -384 160.650 167.380 166.707 USD -64,015 175.84 Profit of 3,508 on sale
2025-04-08 SELL -48 158.690 173.455 171.979 USD -8,255 176.13 Profit of 199 on sale
2025-04-07 SELL -48 166.010 175.155 174.240 USD -8,364 176.25 Profit of 96 on sale
2025-04-04 SELL -240 171.300 173.990 173.721 USD -41,693 176.30 Profit of 620 on sale
2025-04-01 BUY 418 174.580 182.060 181.312 USD 75,788 176.27
2025-03-31 SELL -141 180.300 182.080 181.902 USD -25,648 176.22 Loss of -801 on sale
2025-03-21 BUY 637 187.150 188.530 188.392 USD 120,006 175.29
2025-03-14 SELL -720 179.380 180.340 180.244 USD -129,776 174.50 Loss of -4,133 on sale
2025-03-07 SELL -90 179.935 181.910 181.713 USD -16,354 174.02 Loss of -692 on sale
2025-03-04 SELL -45 175.220 176.640 176.498 USD -7,942 173.83 Loss of -120 on sale
2025-02-25 BUY 90 181.100 188.560 187.814 USD 16,903 173.61
2025-02-19 SELL -45 176.170 179.980 179.599 USD -8,082 172.88 Loss of -302 on sale
2025-02-13 BUY 135 155.750 155.960 155.939 USD 21,052 174.34
2025-02-12 BUY 45 151.320 152.135 152.053 USD 6,842 174.81
2025-02-11 BUY 180 149.920 153.340 152.998 USD 27,540 175.33
2024-12-30 SELL -1,631 159.800 160.220 160.178 USD -261,250 183.21 Profit of 37,561 on sale
2024-11-18 SELL -735 175.640 176.445 176.365 USD -129,628 178.47 Profit of 1,551 on sale
2024-11-08 SELL -49 199.610 200.890 200.762 USD -9,837 176.34 Loss of -1,197 on sale
2024-10-21 SELL -49 178.980 179.805 179.722 USD -8,806 0.00 Loss of -8,806 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	48	201.320	197.130	197.549	USD 9,482	165.45
2025-11-06	BUY	48	202.940	195.759	196.477	USD 9,431	165.08
2025-11-04	BUY	48	212.980	195.465	197.216	USD 9,466	164.68
2025-10-30	BUY	240	191.435	184.700	185.373	USD 44,490	164.18
2025-10-29	BUY	96	185.050	189.960	189.469	USD 18,189	164.06
2025-10-22	SELL	-192	186.420	190.670	190.245	USD -36,527	163.37 Loss of -5,159 on sale
2025-10-20	BUY	96	195.960	196.775	196.693	USD 18,883	163.02
2025-10-17	BUY	240	190.230	192.910	192.642	USD 46,234	162.86
2025-10-15	BUY	384	192.990	195.385	195.145	USD 74,936	162.69
2025-10-03	BUY	336	183.360	183.580	183.558	USD 61,675	162.41
2025-10-02	BUY	48	181.690	182.280	182.221	USD 8,747	162.29
2025-09-30	BUY	96	176.530	178.200	178.033	USD 17,091	162.10
2025-09-26	BUY	96	167.820	168.190	168.153	USD 16,143	161.98
2025-09-25	BUY	96	161.150	164.385	164.061	USD 15,750	161.98
2025-09-18	BUY	50	160.610	160.690	160.682	USD 8,034	161.99
2025-09-17	BUY	150	154.050	157.100	156.795	USD 23,519	162.04
2025-07-17	SELL	-100	150.150	153.740	153.381	USD -15,338	162.35 Profit of 897 on sale
2025-07-16	BUY	192	150.080	151.790	151.619	USD 29,111	162.43
2025-07-11	SELL	-392	148.170	148.770	148.710	USD -58,294	162.70 Profit of 5,484 on sale
2025-07-02	BUY	2,695	141.350	143.045	142.875	USD 385,049	163.16
2025-06-25	BUY	98	142.500	146.775	146.347	USD 14,342	163.80
2025-06-20	BUY	464	132.460	133.700	133.576	USD 61,979	164.35
2025-06-11	BUY	96	139.620	143.200	142.842	USD 13,713	165.90
2025-06-10	BUY	96	138.210	138.523	138.492	USD 13,295	166.11
2025-06-04	SELL	-48	132.030	134.030	133.830	USD -6,424	167.10 Profit of 1,597 on sale
2025-04-23	BUY	48	165.800	176.730	175.637	USD 8,431	174.96
2025-04-10	SELL	-384	160.650	167.380	166.707	USD -64,015	175.84 Profit of 3,508 on sale
2025-04-08	SELL	-48	158.690	173.455	171.979	USD -8,255	176.13 Profit of 199 on sale
2025-04-07	SELL	-48	166.010	175.155	174.240	USD -8,364	176.25 Profit of 96 on sale
2025-04-04	SELL	-240	171.300	173.990	173.721	USD -41,693	176.30 Profit of 620 on sale
2025-04-01	BUY	418	174.580	182.060	181.312	USD 75,788	176.27
2025-03-31	SELL	-141	180.300	182.080	181.902	USD -25,648	176.22 Loss of -801 on sale
2025-03-21	BUY	637	187.150	188.530	188.392	USD 120,006	175.29
2025-03-14	SELL	-720	179.380	180.340	180.244	USD -129,776	174.50 Loss of -4,133 on sale
2025-03-07	SELL	-90	179.935	181.910	181.713	USD -16,354	174.02 Loss of -692 on sale
2025-03-04	SELL	-45	175.220	176.640	176.498	USD -7,942	173.83 Loss of -120 on sale
2025-02-25	BUY	90	181.100	188.560	187.814	USD 16,903	173.61
2025-02-19	SELL	-45	176.170	179.980	179.599	USD -8,082	172.88 Loss of -302 on sale
2025-02-13	BUY	135	155.750	155.960	155.939	USD 21,052	174.34
2025-02-12	BUY	45	151.320	152.135	152.053	USD 6,842	174.81
2025-02-11	BUY	180	149.920	153.340	152.998	USD 27,540	175.33
2024-12-30	SELL	-1,631	159.800	160.220	160.178	USD -261,250	183.21 Profit of 37,561 on sale
2024-11-18	SELL	-735	175.640	176.445	176.365	USD -129,628	178.47 Profit of 1,551 on sale
2024-11-08	SELL	-49	199.610	200.890	200.762	USD -9,837	176.34 Loss of -1,197 on sale
2024-10-21	SELL	-49	178.980	179.805	179.722	USD -8,806	0.00 Loss of -8,806 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of KRYS

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	183,292	0	271,341	67.6%
2025-09-18	50,436	19	114,048	44.2%
2025-09-17	74,967	0	107,129	70.0%
2025-09-16	111,199	31	139,380	79.8%
2025-09-15	250,161	25	382,144	65.5%
2025-09-12	137,789	0	166,739	82.6%
2025-09-11	108,358	30	141,654	76.5%
2025-09-10	121,167	0	148,926	81.4%
2025-09-09	101,616	0	145,891	69.7%
2025-09-08	116,693	0	127,512	91.5%
2025-09-05	22,038	0	116,693	18.9%
2025-09-04	49,719	0	94,460	52.6%
2025-09-03	54,097	0	98,901	54.7%
2025-09-02	63,004	0	86,341	73.0%
2025-08-29	31,697	0	73,033	43.4%
2025-08-28	43,753	0	80,482	54.4%
2025-08-27	41,556	0	55,189	75.3%
2025-08-26	52,461	0	73,516	71.4%
2025-08-25	49,670	0	71,654	69.3%
2025-08-22	45,270	0	63,836	70.9%
2025-08-21	46,454	0	64,460	72.1%
2025-08-20	48,711	0	64,364	75.7%
2025-08-19	29,185	0	45,139	64.7%
2025-08-18	72,672	0	93,022	78.1%
2025-08-15	46,244	0	61,676	75.0%
2025-08-14	93,020	0	135,754	68.5%
2025-08-13	81,372	0	123,491	65.9%
2025-08-12	62,081	0	81,209	76.4%
2025-08-11	61,427	0	111,390	55.1%
2025-08-08	66,658	0	143,466	46.5%
2025-08-07	69,898	0	103,959	67.2%
2025-08-06	75,137	0	153,985	48.8%
2025-08-05	127,403	8,526	196,364	64.9%
2025-08-04	487,463	6,132	712,723	68.4%
2025-08-01	144,496	0	222,654	64.9%
2025-07-31	74,046	0	105,570	70.1%
2025-07-30	64,909	0	89,625	72.4%
2025-07-29	50,811	78	67,292	75.5%
2025-07-28	103,502	12,661	152,348	67.9%
2025-07-25	84,590	2	136,783	61.8%
2025-07-24	63,081	338	72,553	86.9%
2025-07-23	91,815	0	103,328	88.9%
2025-07-22	71,156	452	86,091	82.7%
2025-07-21	52,942	51	63,221	83.7%
2025-07-18	71,647	102	96,520	74.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE